MA24604A1 - Compositions nouvelles d'inhibiteur selectif de reabsorption de serotonine et d'un b-bloquant - Google Patents

Compositions nouvelles d'inhibiteur selectif de reabsorption de serotonine et d'un b-bloquant

Info

Publication number
MA24604A1
MA24604A1 MA25165A MA25165A MA24604A1 MA 24604 A1 MA24604 A1 MA 24604A1 MA 25165 A MA25165 A MA 25165A MA 25165 A MA25165 A MA 25165A MA 24604 A1 MA24604 A1 MA 24604A1
Authority
MA
Morocco
Prior art keywords
blocker
novel compositions
selective serotonin
reabsorption inhibitor
serotonin reabsorption
Prior art date
Application number
MA25165A
Other languages
English (en)
French (fr)
Original Assignee
Smithkline Beecham Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Plc filed Critical Smithkline Beecham Plc
Publication of MA24604A1 publication Critical patent/MA24604A1/fr

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2072Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2086Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
    • A61K9/209Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat containing drug in at least two layers or in the core and in at least one outer layer
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445Non condensed piperidines, e.g. piperocaine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/06Antimigraine agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/22Anxiolytics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/30Drugs for disorders of the nervous system for treating abuse or dependence
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/30Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/32Alcohol-abuse
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/04Anorexiants; Antiobesity agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5084Mixtures of one or more drugs in different galenical forms, at least one of which being granules, microcapsules or (coated) microparticles according to A61K9/16 or A61K9/50, e.g. for obtaining a specific release pattern or for combining different drugs

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Psychiatry (AREA)
  • Addiction (AREA)
  • Pain & Pain Management (AREA)
  • Epidemiology (AREA)
  • Hospice & Palliative Care (AREA)
  • Child & Adolescent Psychology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
MA25165A 1997-07-11 1998-07-10 Compositions nouvelles d'inhibiteur selectif de reabsorption de serotonine et d'un b-bloquant MA24604A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9714675.7A GB9714675D0 (en) 1997-07-11 1997-07-11 Novel composition

Publications (1)

Publication Number Publication Date
MA24604A1 true MA24604A1 (fr) 1999-04-01

Family

ID=10815744

Family Applications (1)

Application Number Title Priority Date Filing Date
MA25165A MA24604A1 (fr) 1997-07-11 1998-07-10 Compositions nouvelles d'inhibiteur selectif de reabsorption de serotonine et d'un b-bloquant

Country Status (26)

Country Link
EP (1) EP0996466A2 (id)
JP (1) JP2002508003A (id)
KR (1) KR20010021644A (id)
CN (1) CN1262627A (id)
AP (1) AP2000001728A0 (id)
AR (1) AR016128A1 (id)
AU (1) AU9340198A (id)
BG (1) BG104119A (id)
BR (1) BR9810996A (id)
CA (1) CA2295822A1 (id)
CO (1) CO4950552A1 (id)
DZ (1) DZ2556A1 (id)
EA (1) EA200000112A1 (id)
GB (1) GB9714675D0 (id)
HU (1) HUP0003074A3 (id)
ID (1) ID24191A (id)
IL (1) IL133869A0 (id)
MA (1) MA24604A1 (id)
NO (1) NO20000107D0 (id)
OA (1) OA11276A (id)
PE (1) PE99699A1 (id)
PL (1) PL338017A1 (id)
SK (1) SK72000A3 (id)
TR (1) TR200000074T2 (id)
WO (1) WO1999002142A2 (id)
ZA (1) ZA986138B (id)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7417038B1 (en) 1998-10-15 2008-08-26 Imperial Innovations Limited Methods of treating cachexia
MXPA01004381A (es) 1998-11-02 2005-09-08 Elan Corp Plc Composicion de multiparticulado de liberacion modificada.
KR100889069B1 (ko) 1999-10-29 2009-03-17 유로-셀티크 소시에떼 아노뉨 서방성 하이드로코돈 제형
US10179130B2 (en) 1999-10-29 2019-01-15 Purdue Pharma L.P. Controlled release hydrocodone formulations
GB0004003D0 (en) * 2000-02-22 2000-04-12 Knoll Ag Therapeutic agents
AU2738302A (en) 2000-10-30 2002-05-15 Euro Celtique Sa Controlled release hydrocodone formulations
JP2008513430A (ja) * 2004-09-17 2008-05-01 ニューロキュア リミテッド 月経前症候群および月経前不快気分障害の処置のためのピンドロール
CN100469356C (zh) * 2006-09-08 2009-03-18 山东益康药业有限公司 复方阿替洛尔缓释片及其制备方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2732335C2 (de) * 1976-07-27 1983-01-20 Sandoz-Patent-GmbH, 7850 Lörrach Tablette zur enteralen Verabreichung von Indolyloxyalkanolamin-Derivaten
CA2134038C (en) * 1994-06-16 1997-06-03 David Taiwai Wong Potentiation of drug response
EP0714663A3 (en) * 1994-11-28 1997-01-15 Lilly Co Eli Potentiation of drug responses by serotonin 1A receptor antagonists
DK0759299T3 (da) * 1995-08-16 2000-08-07 Lilly Co Eli Potensering af serotoninrespons
EP0792649A1 (en) * 1996-02-29 1997-09-03 Eli Lilly And Company Treatment of sleep disorders

Also Published As

Publication number Publication date
ZA986138B (en) 2000-01-10
HUP0003074A2 (hu) 2001-01-29
GB9714675D0 (en) 1997-09-17
EA200000112A1 (ru) 2000-10-30
SK72000A3 (en) 2000-12-11
DZ2556A1 (fr) 2003-02-15
ID24191A (id) 2000-07-13
AR016128A1 (es) 2001-06-20
CN1262627A (zh) 2000-08-09
PL338017A1 (en) 2000-09-25
HUP0003074A3 (en) 2001-12-28
WO1999002142A2 (en) 1999-01-21
BG104119A (en) 2000-12-29
BR9810996A (pt) 2000-08-08
JP2002508003A (ja) 2002-03-12
PE99699A1 (es) 1999-12-21
NO20000107L (no) 2000-01-10
AP2000001728A0 (en) 2000-03-31
IL133869A0 (en) 2001-04-30
WO1999002142A3 (en) 1999-04-15
EP0996466A2 (en) 2000-05-03
NO20000107D0 (no) 2000-01-10
OA11276A (en) 2003-07-31
KR20010021644A (ko) 2001-03-15
CA2295822A1 (en) 1999-01-21
CO4950552A1 (es) 2000-09-01
TR200000074T2 (tr) 2000-05-22
AU9340198A (en) 1999-02-08

Similar Documents

Publication Publication Date Title
CY2012029I2 (el) Nεα μορφη της 5-ομεπραζολης
FI963398L (fi) Kielenalainen tai poskensisäinen farmaseuttinen koostumus
EE200000365A (et) Bispidiini uued arütmiavastased ühendid
PT1014987E (pt) Composicoes orais de levosimendano
DE69310957D1 (de) Organosiliconzusammensetzungen
MA24626A1 (fr) Compositions parenterales d'alatrofloxacine
NO20002279D0 (no) Sammensetninger av lipidsenkende midler
MA24604A1 (fr) Compositions nouvelles d'inhibiteur selectif de reabsorption de serotonine et d'un b-bloquant
EP1023068A4 (en) ALPHA 1a ADRENORE RECEPTOR ANTAGONISTS
ID16838A (id) Komposisi dekafluoropentana
ID17419A (id) Komposisi dekafluoropentana
EP0824453A4 (en) NEW USES OF HEPTAFLUORPROPAN
FI991343A7 (fi) Dihydropolyprenolien öljykoostumus
KR960031416U (ko) 투포원연사기의 스핀들
UA1629S (uk) Набір фестонів "веснянка-5"
UA1499S (uk) Набір етикеток "гусарська"
UA1904S (uk) Набір етикеток "недригайлівська"
UA1498S (uk) Набір етикеток "сумська горобинова"
UA1496S (uk) Набір етикеток "зубровка"
UA1478S (uk) Набір знаків розрізнення
UA1693S (uk) Набір етикеток "суми"
UA2100S (uk) Комплект етикеток "хортиця"
UA2400S (uk) Набір етикеток "ужгород"
UA2918S (uk) Комплект етикеток "славутич"
UA2189S (uk) Комплект етикеток "стольник"